Management of Children with Myelodysplasia: Urological Alternatives
- 1 December 1990
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of Urology
- Vol. 144 (6), 1446-1449
- https://doi.org/10.1016/s0022-5347(17)39763-x
Abstract
Recent reports have suggested that the prophylactic use of clean intermittent catheterization in selected infants with myelodysplasia and with normal upper tracts may prevent their deterioration. The selection of these patients at risk depends on urodynamic criteria. We reviewed our experience with clean intermittent catheterization instituted when upper tract deterioration was found. Of 130 patients with myelodysplasia followed at our clinic 25 (19%) had or presented with radiological upper urinary tract deterioration. A total of 21 patients had vesicoureteral reflux and 4 had hydronephrosis without reflux. Treatment consisted of clean intermittent catheterization alone in 5 patients and combined with anticholinergic medication in 16. Four patients with no post-void residual urine were carefully observed without intervention. Urodynamic evaluation was performed selectively in 11 of these 25 patients for persistence of upper urinary tract deterioration or urinary incontinence after institution of treatment. Of the 21 children with reflux 19 (90%) had resolution or improvement for an average followup of 47 months. Hydronephrosis completely resolved in the 4 patients without reflux. Thus, the over-all resolution or improvement rate was 92% for an average of 41 months. Although these excellent results may not be superior to the prophylactic use of clean intermittent catheterization, they validate the assumption that upper tract deterioration can be reversed. The application of current urodynamic selection criteria may result in overtreating a significant number of infants who otherwise may not have upper tract deterioration. Further refinements in these criteria may be necessary to select better not only patients at risk but also to determine the frequency of imaging necessary in this urologically heterogeneous population. In addition, careful consideration should be given to urethral dilation as a third and equally viable alternative to prevent upper tract deterioration.This publication has 14 references indexed in Scilit:
- Urethral Dilation Improves Bladder Compliance in Children with Myelomeningocele and High Leak Point PressuresJournal of Urology, 1990
- The Prophylactic Use of Clean Intermittent Catheterization in the Treatment of Infants and Young Children with Myelomeningocele and Neurogenic Bladder DysfunctionJournal of Urology, 1988
- Implications of Hydronephrosis in the Newborn with MyelodysplasiaJournal of Urology, 1986
- The Value of Urodynamic Testing in the Management of Neonates with Myelodysplasia: A Prospective StudyJournal of Urology, 1986
- Management of Reflux in the Myelodysplastic ChildJournal of Urology, 1983
- The Management of Vesicoureteral Reflux in Children with MyelodysplasiaJournal of Urology, 1982
- Prognostic Value of Urodynamic Testing in Myelodysplastic PatientsJournal of Urology, 1981
- Fate of Vesicoureteral Reflux in Children with Neuropathic Bladders Managed by Intermittent CatheterizationJournal of Urology, 1981
- Further Observations on Self-catheterizationJournal of Urology, 1976
- Clean, Intermittent Self-Catheterization in the Treatment of Urinary Tract DiseaseJournal of Urology, 1972